Early results of photorefractive keratectomy for myopic astigmatism

被引:0
|
作者
Kaskaloglu, M [1 ]
机构
[1] EGE UNIV,DEPT OPHTHALMOL,IZMIR,TURKEY
来源
JOURNAL OF REFRACTIVE SURGERY | 1996年 / 12卷 / 02期
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
BACKGROUND: The Technolas Keracor 116 excimer laser has been used to correct myopic astigmatism, The purpose of this study was to evaluate the early results in our patients. METHODS: The Technolas Keracor 116 excimer utilizes a scanning beam to correct myopic astigmatism, Following the correction of the astigmatic error, spherical myopic component is then treated, Twenty-eight eyes with myopic astigmatism were treated utilizing a 4 x 12 mm ablation zone for astigmatism and 4.5 mm to 6.6 mm transition zone for the spherical component at the same session. The mean preoperative spherical equivalent refraction was -4.87 +/- 3.48 diopters (D) (range: -1.00 to -14.25) and the mean preoperative astigmatic error was 2.53 +/- 1.49 D (range: -1.00 to -6.00 D) All eyes received dexamethasone eye drops for 3 months. RESULTS: At 6 months, the mean spherical equivalent refraction was +0.23 D (range +1.38 to -1.50 D), the mean postoperative refractive cylinder was -0.16 +/- 0.99 D (range: +1.50 to -2.00 D) and 78% of the eyes had a refraction within +/- 1 D, Fifty-five percent achieved 20/40 or better uncorrected visual acuity. In three cases there was one line loss and in two cases there was two line loss in best corrected spectacle visual acuity. CONCLUSIONS: Early results from this study suggest that excimer laser photorefractive keratectomy effectively reduces myopic astigmatism. The treatment of astigmatism offers a new challenge for excimer laser corneal surgery. Lasers utilize different methods to control the beam that reshapes the cornea.(1-5)
引用
收藏
页码:S258 / S260
页数:3
相关论文
共 50 条
  • [1] PHOTOREFRACTIVE KERATECTOMY FOR COMPOUND MYOPIC ASTIGMATISM
    MCDONNELL, PJ
    CAMPOS, M
    HERTZOG, L
    GARBUS, JJ
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1993, 202 (03) : 238 - 244
  • [2] Photorefractive keratectomy for compound myopic astigmatism
    Haw, WW
    Manche, EE
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 130 (01) : 12 - 19
  • [3] Photorefractive keratectomy with an ablatable mask for myopic astigmatism
    Eggink, CA
    de Boo, TM
    Lemmens, WAJG
    Deutman, AF
    [J]. JOURNAL OF REFRACTIVE SURGERY, 1999, 15 (05) : 550 - 555
  • [4] Surgically induced astigmatism after hyperopic and myopic photorefractive keratectomy
    Yi, DH
    Petroll, M
    Bowman, RW
    McCulley, JP
    Cavanagh, HD
    [J]. JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2001, 27 (03): : 396 - 403
  • [5] TREATMENT OF MYOPIC ASTIGMATISM WITH PHOTOREFRACTIVE KERATECTOMY USING AN ERODIBLE MASK
    CHERRY, PMH
    TUTTON, MK
    BELL, A
    NEAVE, C
    FICHTE, C
    [J]. JOURNAL OF REFRACTIVE AND CORNEAL SURGERY, 1994, 10 (02): : S239 - S245
  • [6] Excimer laser photorefractive keratectomy for high myopia and myopic astigmatism
    Gabrieli, CB
    Pacella, E
    Abdolrahimzadeh, S
    Regine, F
    Mollo, R
    [J]. OPHTHALMIC SURGERY AND LASERS, 1999, 30 (06): : 442 - 448
  • [7] Wavefront-guided photorefractive keratectomy for myopia and myopic astigmatism
    Nagy, ZZ
    Palágyi-Deák, I
    Kelemen, E
    Kovács, A
    [J]. JOURNAL OF REFRACTIVE SURGERY, 2002, 18 (05) : S615 - S619
  • [8] Results of photorefractive keratectomy in patients with mixed astigmatism
    Nagy, ZZ
    Suveges, I
    Nemeth, J
    Fust, A
    Munkacsy, G
    Turi, E
    [J]. SOE '97 - XI CONGRESS OF THE EUROPEAN SOCIETY OF OPHTHALMOLOGY, VOLS 1 AND 2, 1997, : 1053 - 1055
  • [9] Photorefractive keratectomy results as a function of preoperative astigmatism
    Garner, LP
    Crosser, VT
    Tauber, J
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 2595 - 2595
  • [10] Photorefractive treatment of myopic astigmatism by laser-assisted in situ Keratomileusis and Photorefractive Keratectomy
    Al-Samak, Ahmed Mohammed
    Shehab, Sajid Yousef
    [J]. JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2021, 28 (01): : 1 - 6